The adjustment of the medical insurance catalogue starts! Plans to add 4 types of drugs to be approved before June 30, new drugs can be declared

On the evening of June 9th, the National Medical Insurance Administration released a message on its official website to solicit public opinions on the "Work Plan for the 2021 National Medical Insurance Drug List Adjustment" (hereinafter referred to as the "Plan") and the "2021 National Medical Insurance Drug List Adjustment Application Guidelines"
.

Reading through the two major documents, some of the new practices proposed by the National Medical Insurance Bureau deserve the attention of the industry
.

And the "plan" also pointed out that, considering the functional positioning of basic medical insurance, the clinical needs of drugs, and the affordability of funds, four types of drugs will be included in the drug catalog in 2021:

1.
From January 1, 2016 to June 30, 2021, new generic drugs approved for marketing by the State Drug Administration;

2.
During the period from January 1, 2016 to June 30, 2021, drugs with major changes in indications or functions and indications approved by the State Drug Administration;

3.
Drugs for the treatment of respiratory diseases related to new coronary pneumonia;

4.
Drugs included in the "National Essential Drug List (2018 Edition)"
.

According to requirements, the public can make comments and suggestions before 17:00 on June 16, 2021 (Wednesday)
.

It is worth noting that in the scope of the drugs that are delineated from the catalog, except for the drugs that have been revoked, revoked or cancelled by the national drug regulatory authority, the National Medical Insurance Bureau has clearly considered the clinical value, adverse reactions, and Drugs whose economics and other factors are assessed to be more risky than benefits
.